Bad market news can’t stop The Good Morning Cash Trade

It stunned the world –

January 27th, 2025.

Nvidia crashed. And the AI sector buckled. Triggering a $1 trillion sell-off. 

In a flash, investors saw years of savings vaporized. If that happened to you, it’s not your fault.

You don’t have a crystal ball to predict the market.

But you don’t need to. At least not anymore…

Dave Aquino, a former Wall Street insider with 25 years of experience…

Says there was a directionless trade you could’ve placed that morning. It could’ve handed you a $150 payout. 

Depending on your position size, you could’ve made more than…

  • $200…
  • $250…
  • $350…
  • $400 in a single morning…

During the worst tech crash in recent history. 

This is a repeatable, virtually fire-proof trading plan that doesn’t require you to know market direction.

It’s unlike anything you’ve seen before. 

We call it “The Good Morning Cash Plan.”

And you could be just 90 minutes away from your first winning trade.

Check out Dave’s FREE training to place your first trade. 

Access the $150 Daily Cash Plan HERE now.

To your trading success

Drew Day
Founder, Base Camp Trading





Just For You

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?

Written by Jordan Chussler. Published 11/19/2025. 

Hims and Hers Health logo positioned with telehealthcare provider in background.

Key Points

  • Shares of HIMS have seen gains of 173% and 146% this year, but they’ve also seen massive double-digit corrections after each run-up in price. 
  • The company’s management was able to achieve profitability just three years after its IPO.
  • Analysts’ forecast an average 12-month price target nearly 25% higher than where the stock is trading today.

Most headlines in the health care sector are dominated by Big Pharma giants. Legacy companies such as AbbVie (NYSE: ABBV), Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE), and Merck (NYSE: MRK)—and their lineup of game-changing drugs—receive the lion’s share of attention. But one newcomer is making a splash, and investors seeking growth opportunities in the health space should be paying attention. 

Founded in November 2017, Hims & Hers Health (NYSE: HIMS) went public in January 2021. By the end of 2024, the consumer-focused health platform posted its first profitable year, reporting net income of $126 million. 

I interviewed 600 crypto millionaires – here’s what’s coming (Ad)

The smartest minds in the market are positioning themselves for something unprecedented…

Learn how to capitalize on the early stages of a historic crypto bull run before it’s too late.Get your FREE copy of “Crypto Revolution” now

While that figure is small compared with mega-cap peers, it demonstrates a level of financial discipline rarely seen among companies less than five years removed from their IPO. Combined with operations at the intersection of several high-demand industries, this makes Hims & Hers an intriguing buy-and-hold prospect for some investors.  

A Turbulent Year for Shareholders 

On the fundamentals side, the young company’s debt management has been notable. That strength is underscored by a nearly 244% increase in net cash from operating activities from 2023 to 2024. 

When Hims & Hers Health reported Q3 financials on Nov. 3, it missed earnings by just 3 cents and beat revenue expectations, reporting $598.98 million, a 49.2% year-over-year increase.

In his comments, CEO and cofounder Andrew Dudum highlighted that “At the end of the quarter, subscribers using personalized solutions grew 50% year-over-year, helping drive nearly 50% in year-over-year revenue growth.” 

Notably, the company’s debt-to-equity ratio of 1.67 and its forward price-to-earnings (P/E) ratio of 52.79—a marked improvement from its trailing 12-month P/E of 67.33—suggest analysts expect earnings to rise next year, from $0.29 per share to about $0.52 per share (more than 79%). 

Since 2021, Hims & Hers has averaged annual EBITDA growth of 37.14%, revenue growth of 77.85%, and earnings per share (EPS) growth of 169.63%.

Despite these solid fundamentals, 2025 has required a strong stomach for HIMS shareholders. The stock’s performance this year has resembled a roller coaster, with rapid rallies followed by sharp declines. 

From Jan. 2 to Feb. 19, HIMS gained nearly 173% before giving back more than 63% by April 22. By May 19 it had climbed nearly 146% again, then plunged about 36% by June 25. At the end of July it had regained roughly 60%, and at the time of writing the stock is about 45% below that high.

HIMS Is at the Center of Multiple High-Growth Industries 

Overall, since going public the stock is up nearly 139%. Hims & Hers has shown rapid growth while management has produced disciplined balance sheets. The company’s accessible, direct-to-consumer telehealth model places it at the intersection of several high-growth markets.

According to market consultancy Grand View Research, the sexual health supplement market is projected to grow at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2030.

The hair thinning market is forecast to expand at a CAGR of 10.85% in the same period, while the telehealth market is expected to grow at a CAGR of 24.68%. 

Perhaps most notably, Hims & Hers also offers compounded GLP-1 injections, which use the same class of active ingredients found in Novo Nordisk’s (NYSE: NVO) Ozempic and Wegovy. The GLP-1 weight-loss market is projected to grow at a CAGR of about 18.54% during the forecast period. 

Additionally, Dudum said on the company’s Q3 earnings call that Hims & Hers is in ongoing discussions with Novo Nordisk to distribute both injection and oral formulations of Wegovy on its platform, pending FDA approval.

Here’s What Wall Street Thinks of HIMS

Ten of the 15 analysts covering Hims & Hers rate it a Hold, and the stock carries a consensus Reduce rating. Still, the 15 analysts’ average 12-month price target is $45.27, implying potential upside of about 24.5%. 

However, the current level of short interest may give prospective investors pause: it stands at roughly 37.54% of the company’s float. For long-term investors, though, institutional ownership—nearly 64%—offers a countervailing vote of confidence.

Underscoring that institutional bullishness, over the past 12 months 425 institutional buyers have added about $2.31 billion in inflows, compared with 194 institutional sellers who withdrew roughly $1.17 billion.

This email communication is a sponsored message provided by Base Camp Trading, a third-party advertiser of MarketBeat. Why did I receive this message?. 

If you need help with your account, please contact our South Dakota based support team at contact@marketbeat.com.

If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.

© 2006-2025 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. U.S.A..

Today’s Bonus Content: Markets React: Shutdown Drama, Tariffs & a Moody Consumer (Click to Opt-In)

Unknown's avatar

Published by RJ Hamster

I was born on 6 August 1956 in San Francisco, California to Janet and (the late) Richard Hovis. I grew up in Santa Monica, California where I attended elementary, junior high school, and high school (graduating in 1974), in addition to involvement in sports and recreation (Little League +, the Boy’s Club ++). Further, it was in elementary school – St. Augustine’s By-the -Sea Parish School that I found, and made the choice to truly journey with God. I attended Arizona State University from 1974 to 1977 – seeking to become an architect, however, I was not accepted, and, as such, I graduated with a Liberal Arts degree. Upon graduation from Arizona State University, I attended Cal Poly San Luis Obispo and studied City and Regional Planning at the Master’s level. I successfully completed one (1) year in a two (2) year program – I did not complete the Master’s degree in City and Regional Planning – due to personal reasons. I returned to Santa Monica where I started (October 1979) my career as graphic designer with Exxon Company, USA. I spent five years with Exxon Company, USA. While working with Exxon Company, USA I was accepted into architectural school – Sci-Arc in Southern California, however, I did not attend preferring to stay with Exxon.. In 1982 I married Laura Flosi and in April 1983 we had our one and only child – Lauren Alain Hovis – a gift from God. We moved to Phoenix, Arizona in 1984 from Los Angeles, where I went to work as a graphic designer with Kitchell CEM (from 1985 -1987). From 1987 – 1995 I was an independent contractor, and a registered representative in mortgage finance, financial management, graphic design, and drafting. Further, I attended the University of Phoenix and successfully obtained a Master’s in Business Administration (MBA) in 1982. I was also a member of the Scottsdale Jaycees, where I became very involved in community events and projects. In 1994, I accepted a cartography position with the Defense Mapping Agency in Reston, Virginia. As such, I relocated from Phoenix to Reston. In 1998, I was accepted and worked as a Visual Information Officer with the Central Intelligence Agency. In 2002, I worked as a Support Officer until my retirement (due to a need for shoulder surgery) in September 2018. Away from my Federal Government service, I have been involved in various organizations and activities in Northern Virginia. In November of 2011, I married Rebecca Ouellette in Santa Monica, California. I reside in San Tan Valley, AZ with my two hamster - Jess and Timothy, our fish, our lizard - RJ Lizard., and our cats - Pearl and Grey. As to hobbies, I enjoy playing sports, attending sporting events, mentoring individuals from financial management to hamsters, building models, photography, travel, multimedia design, managing partner for RJ Hamster, and jazz – smooth jazz to a samba or a bossa nova. Love and God Bless, Peter – aka RJ Hamster Jo hi

Leave a Comment